Neurosurgery Market, By Device Type (Neurosurgery Software, Radiosurgery Systems, and Neuro Interventional Devices), By Surgery Type (Spine Surgery, and Functional Neurosurgery), By Application (Brain Tumors, Cortical Mapping, Parkinson's disease, and Chronic Pain), By End-User (Ambulatory Surgical Centers, Neurosurgery Centers, Hospitals, Research Centers, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034

Report Code: PMI516023 | Publish Date: March 2024 | No. of Pages: 170

Neurosurgery Market Overview

Neurosurgery Market was valued at US$ 5.8 Billion in 2024 and is projected to grow at a CAGR of 10.6% to reach US$ 14.4 Billion by 2034.

[PDF] Neurosurgery Market  is a specialized field of medicine that focuses on the diagnosis, treatment, and surgical management of disorders affecting the nervous system, including the brain, spinal cord, and peripheral nerves. Neurosurgeons are highly trained medical professionals who perform surgical procedures to address a wide range of neurological conditions and diseases.  

Neurosurgery Market Drivers & Restraints

Aging Population

As individuals age, they become more susceptible to a range of neurological conditions and disorders. These may include neurodegenerative disorder therapeutics like Alzheimer's disease and Parkinson's disease, as well as conditions such as stroke and brain tumors. This increased incidence drives the demand for neurosurgical interventions to diagnose, manage, and treat these conditions.  

Personalized Medicine

Personalized medicine raises important ethical considerations, such as patient consent for genetic testing and data privacy. It also empowers patients to make more informed decisions about their treatment options based on a personalized risk-benefit analysis. As the field of genomics and molecular medicine continues to advance, personalized medicine will likely become an increasingly integral part of neurosurgical practice. It has the potential to revolutionize how neurological conditions and brain tumors are diagnosed and treated, ultimately leading to better patient outcomes and more efficient healthcare delivery.  

Restrains:

Safeguarding patient privacy and ensuring the security of sensitive medical data are ethical imperatives. Unauthorized access to patient records or breaches of confidentiality can damage patient trust.  Laws like the Health Insurance Portability and Accountability Act (HIPAA) in the United States mandate strict patient data protection. Violations can result in severe legal penalties.   

Neurosurgery Market Segmentations & Regional Insights

Neurosurgery Market is segmented based on Device Type, Surgery Type, Application, End-User and Region.

Device Type Insight

On the basis of Device Type, Neurosurgery Market is segmented into Neurosurgery Software, Radiosurgery Systems, and Neuro Interventional Devices. Neurosurgery Software is expected to dominate the target market growth as neurosurgery software is an essential tool in the field. It encompasses a range of software applications used for surgical planning, intraoperative guidance, image analysis, and patient data management.

Surgery Type Insights

On the basis of Surgery Type, Neurosurgery Market is segmented into Spine Surgery, and Functional Neurosurgery. Spine Surgery is expected to dominate the target market growth as spine surgery is a common and integral part of the neurosurgery market. It involves surgical interventions to address conditions affecting the spinal column, including the vertebrae, discs, and surrounding tissues.

Application Insights

On the basis of Application, Neurosurgery Market is segmented into Brain Tumors, Cortical Mapping, Parkinson's disease, and Chronic Pain. Brain Tumors is expected to dominate the target market growth as brain tumors are a common focus of neurosurgery, and their treatment is a significant component of the neurosurgery market.

End-User Insights

On the basis of End-User, Neurosurgery Market is segmented into Ambulatory Surgical Centers, Neurosurgery Centers, Hospitals, Research Centers, and Others. Hospital is expected to dominate the target market growth as hospitals are a fundamental component of the neurosurgery market. They offer a comprehensive range of services and resources to diagnose, treat, and manage various neurological conditions and perform neurosurgical procedures.

Neurosurgery Market Regional Insights:

On region the Neurosurgery Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

North America market is estimated to witness a significantly high revenue share over the forecast period. North America has a well-developed neurosurgery market, with a high level of technological advancement and access to specialized care. Major neurosurgery centers and academic institutions are concentrated in this region. The prevalence of neurological conditions, including brain tumors, stroke, and neurodegenerative diseases, drives the demand for neurosurgical services.

Asia Pacific market is also estimated to witness a fastest revenue share over the forecast period as China has witnessed rapid growth in its neurosurgery market, driven by a large population, increasing healthcare investment, and improvements in healthcare infrastructure. The prevalence of neurological conditions like stroke and brain tumors has also contributed to demand for neurosurgical services

Recent Development:

The New Launched Product News,

  • In July 2023, Anuncia Medical Successfully Launched Second Generation Device to Treat Hydrocephalus at Several Leading Neurosurgical Centers Across the United States. Neurosurgeons in the US and abroad now have a new way to reduce the effects of hydrocephalus by giving the 30 million people who suffer from this neurological ailment better access to possibly life-saving treatment.
  • In July 2021, Omniscient Neurotechnology launched Quicktome Brain Mapping Platform for Neurosurgery after regulatory clearance in United States, Canada and Australia. The "connectomics" science, which studies how the brain is connected, is incorporated into normal neurosurgery planning using the software Quicktome. Critically, Quicktome helps neurosurgeons make more informed judgments and lowers surgical uncertainty by visualizing networks that are responsible for complex activities like language, movement, and cognition.

Report Scope:

Attribute

Details

Base year for estimation

2023

Forecast period

2024 – 2034

Market representation

Revenue in USD Billion & CAGR from 2024 – 2034

Market Segmentation

By Device Type - Neurosurgery Software, Radiosurgery Systems, and Neuro Interventional Devices

By Surgery Type - Spine Surgery, and Functional Neurosurgery

By Application - Brain Tumors, Cortical Mapping, Parkinson's disease, and Chronic Pain

By End-User - Ambulatory Surgical Centers, Neurosurgery Centers, Hospitals, Research Centers, and Others

Regional scope

North America - U.S., Canada

Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe

Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific

Latin America - Brazil, Mexico, Argentina, Rest of Latin America

Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2024 – 2034

Neurosurgery Market Competitive Landscape & Key Players

The key players operating the Neurosurgery Market includes, Terumo Corporation, Clarus Medical LLC., Medtronic, Integra LifeSciences, Resonetics, Boston Scientific Corporation, Penumbra Inc., Stryker, Braun SE., and Adeor Medical AG.   

Neurosurgery Market Company Profile

  • Terumo Corporation
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Clarus Medical LLC.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Medtronic
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Integra LifeSciences
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Resonetics
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Boston Scientific Corporation
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Penumbra Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Stryker
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Braun SE.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Adeor Medical AG
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  1. The Last Word
    • Future Impact
    • About Us
    • Contact

FAQs

The Neurosurgery Market is segmented into Device Type, Surgery Type, Application, End-User and Region.

Neurosurgery Market is driven by factors like aging population and personalized medicine.

By region, the Neurosurgery Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America market is estimated to witness a significantly high revenue share over the forecast period.

The key players operating the Neurosurgery Market includes, Terumo Corporation, Clarus Medical LLC., Medtronic, Integra LifeSciences, Resonetics, Boston Scientific Corporation, Penumbra Inc., Stryker, Braun SE., and Adeor Medical AG.

Neurosurgery Market was valued at US$ 5.8 Billion in 2024 and is projected to grow at a CAGR of 10.6% to reach US$ 14.4 Billion by 2034.